BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 36978081)

  • 1. The CLDN5 gene at the blood-brain barrier in health and disease.
    Hashimoto Y; Greene C; Munnich A; Campbell M
    Fluids Barriers CNS; 2023 Mar; 20(1):22. PubMed ID: 36978081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The region-selective regulation of endothelial claudin-5 expression and signaling in brain health and disorders.
    Chiba H; Ichikawa-Tomikawa N; Imura T; Sugimoto K
    J Cell Physiol; 2021 Oct; 236(10):7134-7143. PubMed ID: 33694168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mosaic deletion of claudin-5 reveals rapid non-cell-autonomous consequences of blood-brain barrier leakage.
    Vázquez-Liébanas E; Mocci G; Li W; Laviña B; Reddy A; O'Connor C; Hudson N; Elbeck Z; Nikoloudis I; Gaengel K; Vanlandewijck M; Campbell M; Betsholtz C; Mäe MA
    Cell Rep; 2024 Mar; 43(3):113911. PubMed ID: 38446668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.
    Neuhaus W; Piontek A; Protze J; Eichner M; Mahringer A; Subileau EA; Lee IM; Schulzke JD; Krause G; Piontek J
    Biomaterials; 2018 Apr; 161():129-143. PubMed ID: 29421550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent de novo mutations in CLDN5 induce an anion-selective blood-brain barrier and alternating hemiplegia.
    Hashimoto Y; Poirier K; Boddaert N; Hubert L; Aubart M; Kaminska A; Alison M; Desguerre I; Munnich A; Campbell M
    Brain; 2022 Oct; 145(10):3374-3382. PubMed ID: 35714222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tight junction proteins at the blood-brain barrier: far more than claudin-5.
    Berndt P; Winkler L; Cording J; Breitkreuz-Korff O; Rex A; Dithmer S; Rausch V; Blasig R; Richter M; Sporbert A; Wolburg H; Blasig IE; Haseloff RF
    Cell Mol Life Sci; 2019 May; 76(10):1987-2002. PubMed ID: 30734065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Cell Senescence Contributes to Blood-Brain Barrier Breakdown.
    Yamazaki Y; Baker DJ; Tachibana M; Liu CC; van Deursen JM; Brott TG; Bu G; Kanekiyo T
    Stroke; 2016 Apr; 47(4):1068-77. PubMed ID: 26883501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.
    Harati R; Hammad S; Tlili A; Mahfood M; Mabondzo A; Hamoudi R
    PLoS One; 2022; 17(1):e0262152. PubMed ID: 35025943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-5-Binders Enhance Permeation of Solutes across the Blood-Brain Barrier in a Mammalian Model.
    Hashimoto Y; Shirakura K; Okada Y; Takeda H; Endo K; Tamura M; Watari A; Sadamura Y; Sawasaki T; Doi T; Yagi K; Kondoh M
    J Pharmacol Exp Ther; 2017 Nov; 363(2):275-283. PubMed ID: 28819070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducers of the endothelial cell barrier identified through chemogenomic screening in genome-edited hPSC-endothelial cells.
    Roudnicky F; Zhang JD; Kim BK; Pandya NJ; Lan Y; Sach-Peltason L; Ragelle H; Strassburger P; Gruener S; Lazendic M; Uhles S; Revelant F; Eidam O; Sturm G; Kueppers V; Christensen K; Goldstein LD; Tzouros M; Banfai B; Modrusan Z; Graf M; Patsch C; Burcin M; Meyer CA; Westenskow PD; Cowan CA
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):19854-19865. PubMed ID: 32759214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of a mutated fragment of Clostridium perfringens enterotoxin to endothelial claudin-5 and its modulation of cerebral vascular permeability.
    Liao Z; Yang Z; Piontek A; Eichner M; Krause G; Li L; Piontek J; Zhang J
    Neuroscience; 2016 Jul; 327():53-63. PubMed ID: 27095710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.
    Beard RS; Hoettels BA; Meegan JE; Wertz TS; Cha BJ; Yang X; Oxford JT; Wu MH; Yuan SY
    J Cereb Blood Flow Metab; 2020 Feb; 40(2):374-391. PubMed ID: 30574832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.
    Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE
    Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.
    Kakogiannos N; Ferrari L; Giampietro C; Scalise AA; Maderna C; Ravà M; Taddei A; Lampugnani MG; Pisati F; Malinverno M; Martini E; Costa I; Lupia M; Cavallaro U; Beznoussenko GV; Mironov AA; Fernandes B; Rudini N; Dejana E; Giannotta M
    Circ Res; 2020 Sep; 127(8):1056-1073. PubMed ID: 32673519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders.
    Fiorentino M; Sapone A; Senger S; Camhi SS; Kadzielski SM; Buie TM; Kelly DL; Cascella N; Fasano A
    Mol Autism; 2016; 7():49. PubMed ID: 27957319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silver nanoparticles induce tight junction disruption and astrocyte neurotoxicity in a rat blood-brain barrier primary triple coculture model.
    Xu L; Dan M; Shao A; Cheng X; Zhang C; Yokel RA; Takemura T; Hanagata N; Niwa M; Watanabe D
    Int J Nanomedicine; 2015; 10():6105-18. PubMed ID: 26491287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular stabilization via blood-brain barrier regulation prevents seizure activity.
    Greene C; Hanley N; Reschke CR; Reddy A; Mäe MA; Connolly R; Behan C; O'Keeffe E; Bolger I; Hudson N; Delaney C; Farrell MA; O'Brien DF; Cryan J; Brett FM; Beausang A; Betsholtz C; Henshall DC; Doherty CP; Campbell M
    Nat Commun; 2022 Apr; 13(1):2003. PubMed ID: 35422069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model.
    Nishitsuji K; Hosono T; Nakamura T; Bu G; Michikawa M
    J Biol Chem; 2011 May; 286(20):17536-42. PubMed ID: 21471207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts.
    Hamm S; Dehouck B; Kraus J; Wolburg-Buchholz K; Wolburg H; Risau W; Cecchelli R; Engelhardt B; Dehouck MP
    Cell Tissue Res; 2004 Feb; 315(2):157-66. PubMed ID: 14615934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.